Research Topics
| Saadia SheraziSummaryAffiliation: University of Rochester Country: USA Publications
| Collaborators
|
Detail Information
Publications
Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillatorSaadia Sherazi
Department of Community and Preventive Medicine, University of Rochester Medical Center, PO Box 644, 601 Elmwood Ave, Rochester, NY 14642, USA
Mayo Clin Proc 83:1139-41. 2008..With increased knowledge about managing the withdrawal of this potentially life-prolonging therapy, physicians are likely to become more skilled at caring for dying patients with an ICD...
Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillatorsSaadia Sherazi
Department of Medicine, Unity Health System, Rochester, NY 14626, USA
Cardiol J 17:267-73. 2010..Information is limited regarding the knowledge and attitudes of physicians typically involved in the referral of patients for implantable cardioverter-defibrillator (ICD) implantation...
Corrected QT interval as a predictor of mortality in elderly patients with syncopeAshim Aggarwal
Department of Internal Medicine, Unity Health System, 1555 Long Pond Road, Rochester, NY 14616, USA
Cardiol J 18:395-400. 2011..However, its association with all cause or cardiac mortality in the general population remains unclear. We evaluated the relationship between prolonged QTc and total mortality among patients with syncope...
Effect of biventricular pacing during a ventricular sensed eventMehmet Kemal Aktas
Cardiology Department, University of Rochester Medical Center, Rochester, New York, USA
Am J Cardiol 103:1741-5. 2009....
Diastolic heart failure: predictors of mortalitySaadia Sherazi
Department of Medicine, Unity Health System, Rochester, NY, USA
Cardiol J 18:222-32. 2011..5 cm/s are predictors of adverse outcomes in diastolic HF patients...
Moxifloxacin-induced torsades de pointesSaadia Sherazi
Unity Health System, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14626, USA
Cardiol J 15:71-3. 2008..Although it is difficult to predict which patients are at risk from TdP, careful assessment of the risk/benefit ratio is important before prescribing drugs known to cause QT prolongation...
